Trimurthi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve Audited Financial Statements for the Quarter and Year ended 31.03.2024

pdf

Novelix Pharmaceuticals Ltd.

13 Apr 2024

39.80

-0.90%

Corp. Note

Trimurthi Ltd - 536565 - Format of the Annual Disclosure to be made by an entity …

BSE India

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Trimurthi Ltd 2 CIN NO. L67120TG1994PLC018956 3 Report filed for FY 2023-2024 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 0 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)0 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Nishitha KalantriDesignation :-Company Secretary and Compliance Officer Name of the Chief Financial Officer :- Vani Manda Designation : -CFO Date: 13/04/2024

pdf

Novelix Pharmaceuticals Ltd.

13 Apr 2024

39.80

-0.90%

Company Update

Trimurthi Ltd - 536565 - PCS Certificate

BSE India

PCS certificate

pdf

Novelix Pharmaceuticals Ltd.

13 Apr 2024

39.80

-0.90%

Company Update

Trimurthi Ltd - 536565 - Compliance Certificate U/R., 7(3)

BSE India

Compliance Certificate u/r., 7(3)

pdf

Novelix Pharmaceuticals Ltd.

13 Apr 2024

39.80

-0.90%

Company Update

Trimurthi Ltd - 536565 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate u/r., 74(5)

pdf

Novelix Pharmaceuticals Ltd.

08 Apr 2024

39.80

-0.90%

Company Update

Trimurthi Ltd - 536565 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication - Trimurthi Limited - Voting Results on resolutions through Postal Ballot through Remote e-Voting Facility Pursuant to Regulation 44 and Regulation 47 of SEBI(LODR) Regulations, 2015, enclosed herewith are the Newspaper Clippings published on 7th April, 2024, with regard to the Voting Results on resolutions through Postal Ballot through Remote e-voting Facility only, vide Postal Ballot Notice dated 5th March 2024

pdf

Novelix Pharmaceuticals Ltd.

06 Apr 2024

39.80

-0.90%

AGM

Trimurthi Ltd - 536565 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

BSE India

Pursuant to Regulation 44 of SEBI (LODR) Regulations 2015 and Section 108 of the Companies Act, 2013, attached herewith are: 1. Voting Results as required under Regulation 44(3) of SEBI (LODR) Regulations, 2015 on resolutions through Postal Ballot only through Remote E-voting vide Postal Ballot Notice Dated 05th March, 2024. 2. Scrutinizer''s Report

pdf

Novelix Pharmaceuticals Ltd.

20 Mar 2024

39.80

-0.90%

Company Update

Trimurthi Ltd - 536565 - Draft Letter of Offer

BSE India

Mark Corporate Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer to the Eligible Equity Shareholders of Trimurthi Ltd ("Target Company").

pdf

Novelix Pharmaceuticals Ltd.

13 Mar 2024

39.80

-0.90%

Company Update

Trimurthi Ltd - 536565 - Updates on Open Offer

BSE India

Mark Corporate Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Detailed Public Statement under Regulation 13(4), 14(3) and 15(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended for the attention of the eligible Equity Shareholders of Trimurthi Ltd ("Target Company").

pdf

Is Trimurthi Ltd. worth buying?

7 Votes:

Buy 85.71%

Sell 14.29%